Design Control, CAPA Violations Bring Warning for Transonic

Transonic Systems, a maker of devices to measure cardiac output, has fielded an FDA warning letter for design control and other quality system violations. According to the June 19 letter, the Ithaca, N.Y., company may have manufactured or released some of its COstatus units before the final gate of its “phase and gate approval system.”
The GMP Letter